How many insider declarations has Lim Bryant David filed?

Lim Bryant David has filed 3 public insider declarations with SEC (Form 4).

What is Lim Bryant David's role?

Lim Bryant David's reported role is not specified by the regulator across the filings.

Which companies does Lim Bryant David report trades for?

Lim Bryant David reports trades for 2 companies, including Idera Pharmaceuticals, INC..

What is Lim Bryant David's declared buy vs sell volume?

Across the available history, declared buys total 34k€ and disposals 0.

← Executives ★ Sign in to follow

LB

Lim Bryant David

·SEC (Form 4)

Idera Pharmaceuticals, INC.Prelude Therapeutics Inc

0

申报总数

0

公司

€33,897

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-37.0%

基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the detailed record of transactions filed by Lim Bryant David. Director active across 2 companies, notably Idera Pharmaceuticals, INC.. In total, 3 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €34k. History available since 6 January 2023. The latest transaction was filed on 19 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Lim Bryant David

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Idera Pharmaceuticals, INC. (US)Prelude Therapeutics Inc (US)

申报3 总计

▲

Lim Bryant David

CLO, Interim CFO, Corp Sec.高管2024年12月19日Prelude Therapeutics Inc

US$22,63844SEC ↗

25,000 股@ US$0.905564.5% 占其流量Common StockSEC:0001562180-24-008532:0

标准退出：2025年3月19日 (T+90)

▲

Lim Bryant David

Chief Legal Officer, Corp Sec.高管2023年5月24日Prelude Therapeutics Inc

US$12,93637SEC ↗

2,400 股@ US$5.3935.5% 占其流量Common StockSEC:0001562180-23-004479:0

标准退出：2023年8月22日 (T+90)

◆

Lim Bryant David

SVP AND GENERAL COUNSEL高管2023年1月6日Idera Pharmaceuticals, INC.

0SEC ↗

399,218 股0Common StockSEC:0001415889-23-000765:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

LB

Lim Bryant David

·SEC (Form 4)

Idera Pharmaceuticals, INC.Prelude Therapeutics Inc

0

申报总数

0

公司

€33,897

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-37.0%

基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the detailed record of transactions filed by Lim Bryant David. Director active across 2 companies, notably Idera Pharmaceuticals, INC.. In total, 3 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €34k. History available since 6 January 2023. The latest transaction was filed on 19 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.